Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India · Delayed Price · Currency is INR 520.60
+6.00 (1.17%)
Nov 9, 2026, 12:30 PM IST
Dr. Agarwal's Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,698 | 1,332 | 834.6 | 830.6 | 940.97 | 376.94 |
Depreciation & Amortization | 3,054 | 2,752 | 2,303 | 1,699 | 1,235 | 871.07 |
Other Amortization | 10.6 | 10.6 | 19.7 | 4.9 | 48.1 | 68.5 |
Loss (Gain) From Sale of Assets | 10.5 | -0.3 | 4.3 | -1.9 | -0.4 | 2.36 |
Asset Writedown & Restructuring Costs | - | - | 30.2 | - | - | 37.03 |
Loss (Gain) From Sale of Investments | -91.8 | -144.1 | -171.3 | -246.7 | -46.62 | - |
Stock-Based Compensation | 81.6 | 73.9 | 83.8 | 50.6 | 18.26 | - |
Provision & Write-off of Bad Debts | 254.6 | 224.4 | 148.5 | 112.2 | 117.54 | 111 |
Other Operating Activities | 1,423 | 1,420 | 1,294 | 965.1 | 143.4 | 326.49 |
Change in Accounts Receivable | -701.6 | -541.2 | -436.4 | -292.4 | -313.69 | -211.05 |
Change in Inventory | -299.7 | -137.6 | -264.8 | -152.8 | -24.92 | -46.89 |
Change in Accounts Payable | - | - | - | 360.7 | 128.93 | 168.57 |
Change in Other Net Operating Assets | -65.7 | 200.9 | -274.1 | 130.9 | 84.63 | -60.74 |
Operating Cash Flow | 5,373 | 5,190 | 3,571 | 3,460 | 2,331 | 1,643 |
Operating Cash Flow Growth | 27.77% | 45.32% | 3.22% | 48.43% | 41.85% | 65.72% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -4,924 | -4,480 | -3,087 | -2,309 | -1,566 | -702.39 |
Sale of Property, Plant & Equipment | 4.5 | 8.6 | 5.3 | 42.5 | 5.03 | 8.11 |
Cash Acquisitions | -1,025 | -913.4 | -5,158 | -2,867 | -3,208 | -797.06 |
Sale (Purchase) of Intangibles | -278.8 | -126.3 | -122.5 | -14.2 | -12.28 | -3.49 |
Investment in Securities | 1,445 | 1,258 | 2,239 | -4,122 | -289.98 | - |
Other Investing Activities | 719.5 | 1,168 | -1,381 | 130.6 | -20.12 | -58.68 |
Investing Cash Flow | -4,059 | -3,085 | -7,503 | -9,139 | -5,091 | -1,554 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | 615.2 | 2,452 | 1,731 | 1,110 |
Total Debt Issued | 434.3 | - | 615.2 | 2,452 | 1,731 | 1,110 |
Long-Term Debt Repaid | - | -2,228 | -3,015 | -2,968 | -1,409 | -694.66 |
Lease Payments | -1,496 | -1,332 | -989.5 | -811 | -629.75 | -510.19 |
Total Debt Repaid | -1,721 | -2,228 | -3,015 | -2,968 | -1,409 | -694.66 |
Net Debt Issued (Repaid) | -1,287 | -2,228 | -2,400 | -515.5 | 321.45 | 415.4 |
Issuance of Common Stock | 101.1 | 113.7 | 2,799 | 6,371 | 3,009 | - |
Common Dividends Paid | -15.6 | -10.9 | -7.9 | -7.7 | -4.28 | -0.07 |
Other Financing Activities | -52.3 | -79.1 | -368.8 | -321.5 | -292.74 | -209.25 |
Financing Cash Flow | -1,254 | -2,204 | 3,819 | 5,527 | 3,033 | 354.33 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 60.4 | -98.5 | -113.5 | -152.3 | 273.6 | 444.1 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 448.8 | 710.4 | 484.8 | 1,151 | 765.33 | 940.89 |
Free Cash Flow Growth | 71.95% | 46.53% | -57.88% | 50.38% | -18.66% | - |
Free Cash Flow Margin | 1.90% | 3.42% | 2.83% | 8.64% | 7.52% | 13.52% |
Free Cash Flow Per Share | 1.40 | 2.23 | 1.62 | 4.34 | 3.25 | 4.57 |
Levered Free Cash Flow | -1,287 | -430.44 | -459.61 | 395.88 | 584.17 | 533.38 |
Unlevered Free Cash Flow | -727.65 | 134.19 | 214.51 | 993.5 | 1,034 | 817.12 |
Free Cash Flow After Leases | -1,047 | -621.2 | -504.7 | 339.9 | 135.58 | 430.7 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 79.1 | 79.1 | 322.4 | 321.5 | 292.74 | 207.67 |
Cash Income Tax Paid | 550.6 | 550.6 | 366 | 320.9 | 353.83 | 155.96 |
Change in Working Capital | -1,067 | -477.9 | -975.3 | 46.4 | -125.05 | -150.11 |